← Leaderboards
Howard C Crawford
State University New York Stony Brook
$9,133,680
Attributed
$14,741,716
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,741,716 · 10
By mechanism
R01$8,362,858 · 5
U01$5,840,378 · 2
R21$381,480 · 1
R03$155,000 · 1
R13$2,000 · 1
Top collaborators
- Marina Pasca Di Magliano7 shared
- Richard Z Lin6 shared
- Timothy Louis Frankel4 shared
- Rafael A. Fridman4 shared
- Costas Andreas Lyssiotis4 shared
- Jean-Philippe Francois Marie Coppe2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsMalignant Neoplasm Of PancreasPancreasTumorSignal TransductionPancreatic Ductal AdenocarcinomaPancreatic NeoplasmMediatingIn VitroIn VivoCessation Of LifeCancer EtiologyMouse ModelAblationNeoplastic CellInflammatoryOncogenicTumor ProgressionCytokineMutationEpithelialPancreatic TumorigenesisGenetic
Grant awards (35)
Fibroblast orchestration of the immune response in pancreatic cancer$826,873
U01 · FY2025 · CA
Collagen Signaling in Pancreatic Cancer$658,784
R01 · FY2025 · CA · contact PI
Fibroblast orchestration of the immune response in pancreatic cancer$786,440
U01 · FY2024 · CA
Collagen Signaling in Pancreatic Cancer$630,684
R01 · FY2024 · CA · contact PI
Metaplastic Tuft Cells in Pancreatic Cancer$450,764
R01 · FY2024 · CA · contact PI
Fibroblast orchestration of the immune response in pancreatic cancer$829,209
U01 · FY2023 · CA
Metaplastic Tuft Cells in Pancreatic Cancer$464,998
R01 · FY2023 · CA · contact PI
Fibroblast orchestration of the immune response in pancreatic cancer$844,294
U01 · FY2022 · CA
Metaplastic Tuft Cells in Pancreatic Cancer$464,998
R01 · FY2022 · CA · contact PI
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer$527,973
U01 · FY2021 · CA
Metaplastic Tuft Cells in Pancreatic Cancer$467,825
R01 · FY2021 · CA · contact PI
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer$527,973
U01 · FY2020 · CA · contact PI
Metaplastic Tuft Cells in Pancreatic Cancer$477,977
R01 · FY2020 · CA · contact PI
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer$1,497,616
U01 · FY2017 · CA · contact PI
2017 Matrix Metalloproteinases Gordon Research Conference and Gordon Research Seminar$2,000
R13 · FY2017 · CA · contact PI
Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia$167,592
R21 · FY2016 · CA
ADAM17 in pancreatic cancer and pancreatitis$381,425
R01 · FY2015 · CA · contact PI
Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia$213,888
R21 · FY2015 · CA
ADAM17 in pancreatic cancer and pancreatitis$378,431
R01 · FY2014 · CA · contact PI
ADAM17 in pancreatic cancer and pancreatitis$366,727
R01 · FY2013 · CA · contact PI
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer$295,122
R01 · FY2013 · CA
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer$63,345
R01 · FY2013 · CA
ADAM17 in pancreatic cancer and pancreatitis$390,135
R01 · FY2012 · CA · contact PI
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer$313,959
R01 · FY2012 · CA
ADAM17 in pancreatic cancer and pancreatitis$395,872
R01 · FY2011 · CA · contact PI
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer$313,959
R01 · FY2011 · CA
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer$323,500
R01 · FY2010 · CA
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer$321,631
R01 · FY2009 · CA
MMP-7 IN Pacreatic Cancer and Chronic Pancreatitis$234,031
R01 · FY2008 · CA · contact PI
Pancreatic Tumor Progression in the Absence of ADAM-mediated alpha-secretase Acti$77,500
R03 · FY2008 · CA · contact PI
MMP-7 IN Pacreatic Cancer and Chronic Pancreatitis$234,031
R01 · FY2007 · CA · contact PI
Pancreatic Tumor Progression in the Absence of ADAM-mediated alpha-secretase Acti$77,500
R03 · FY2007 · CA · contact PI
MMP-7 IN Pacreatic Cancer and Chronic Pancreatitis$241,020
R01 · FY2006 · CA · contact PI
MMP-7 IN Pacreatic Cancer and Chronic Pancreatitis$246,820
R01 · FY2005 · CA
MMP-7 IN Pacreatic Cancer and Chronic Pancreatitis$246,820
R01 · FY2004 · CA